stars 1 stars 2 stars 3

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The Company’s multi-platform expertise across the manufacture, delivery, development, and discovery of novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM™ Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery. A robust and diverse pipeline is led by a novel gene-corrected cell therapy poised to enter Phase 3 in mid-2019 and complemented by one-time gene therapy candidates across four lysosomal storage diseases. Several preclinical discoveries are led by an emerging program in cystic fibrosis that uses the AIM vector platform and a capsid that has shown potential across inherited and acquired retinal diseases.

View Top Employees from Abeona Therapeutics
Ticker ABEO
Revenue $837000
Employees 102 (100 on RocketReach)
Founded 2015
Address 1330 Avenue of the Americas 33rd Floor, New York, New York 10019, US
Phone (646) 813-4701
HTML, PHP, Twitter +24 more (view full list)
Category Biotechnology, Gene Therapy, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Human-derived plasma proteins, Pharma, Alpha-1 deficiency, IVIG, Ultra orphan proteins, Rare Disease, Sanfiippo Syndrome Type A, Sanfiippo Syndrome Type B, MPS IIIA, Juvenile Batten Disease, Fanconi anemia
Web Rank 3 Million
Keywords abeona therapeutics, abeona, aboena, abeona therapeutics pipeline, eb-101
Competitors AGTC, Adverum Biotechnologies, Lumos Pharma, Mustang Bio, Voyager Therapeutics, Inc.
SIC 37, 376, 28
NAICS 54, 54171, 33, 541711, 541, 5417

Abeona Therapeutics Questions

The Abeona Therapeutics annual revenue was $837000 in 2023.

Joe Vazzano is the CFO of Abeona Therapeutics.

100 people are employed at Abeona Therapeutics.

Abeona Therapeutics is based in New York, New York.

The NAICS codes for Abeona Therapeutics are [54, 54171, 33, 541711, 541, 5417].

The SIC codes for Abeona Therapeutics are [37, 376, 28].

Top Abeona Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users